000 01481 a2200433 4500
005 20250516203303.0
264 0 _c20140512
008 201405s 0 0 eng d
022 _a1600-0412
024 7 _a10.1111/aogs.12354
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGeirsson, Reynir Tómas
245 0 0 _aHealthy ethical conduct is vital.
_h[electronic resource]
260 _bActa obstetricia et gynecologica Scandinavica
_cApr 2014
300 _a323-4 p.
_bdigital
500 _aPublication Type: Editorial; Introductory Journal Article
650 0 4 _aAdult
650 0 4 _aAntifibrinolytic Agents
_xtherapeutic use
650 0 4 _aBlood Loss, Surgical
_xprevention & control
650 0 4 _aCesarean Section
_xadverse effects
650 0 4 _aChina
_xepidemiology
650 0 4 _aComorbidity
650 0 4 _aComputer Simulation
650 0 4 _aEndometrial Neoplasms
_xmortality
650 0 4 _aEthics, Medical
650 0 4 _aEthics, Research
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLaparoscopy
_xeducation
650 0 4 _aManuscripts, Medical as Topic
650 0 4 _aPeriodicals as Topic
650 0 4 _aPregnancy
650 0 4 _aPrognosis
650 0 4 _aScientific Misconduct
_xethics
650 0 4 _aTranexamic Acid
_xtherapeutic use
700 1 _aAcharya, Ganesh
773 0 _tActa obstetricia et gynecologica Scandinavica
_gvol. 93
_gno. 4
_gp. 323-4
856 4 0 _uhttps://doi.org/10.1111/aogs.12354
_zAvailable from publisher's website
999 _c23663341
_d23663341